A new vaccine approach could help combat future coronavirus pandemics
The nanoparticle-based vaccine shows promise against many variants of SARS-CoV-2, as well as related sarbecoviruses that could jump to humans.
The nanoparticle-based vaccine shows promise against many variants of SARS-CoV-2, as well as related sarbecoviruses that could jump to humans.
Gifted Caribbean high schoolers become SPISE alumni at MIT, and many go on to advanced academic and professional careers.
Ten objects on display in the Koch Institute Public Galleries offer uncommon insights into the people and progress of MIT's cancer research community.
Professor oversaw department growth, strengthened community, and developed outreach programs.
Phoenix Tailings, co-founded by MIT alumni, is creating domestic supply chains for rare earth metals, key to the clean energy transition.
The drug-device combination developed by MIT spinout Lumicell is poised to reduce repeat surgeries and ensure more complete tumor removal.
The new Tayebati Postdoctoral Fellowship Program will support leading postdocs to bring cutting-edge AI to bear on research in scientific discovery or music.
The discovery of pyrene derivatives in a distant interstellar cloud may help to reveal how our own solar system formed.
Novel method to scale phenotypic drug screening drastically reduces the number of input samples, costs, and labor required to execute a screen.
MIT’s innovation and entrepreneurship system helps launch water, food, and ag startups with social and economic benefits.
A new study shows Mars’ early thick atmosphere could be locked up in the planet’s clay surface.
By analyzing X-ray crystallography data, the model could help researchers develop new materials for many applications, including batteries and magnets.
MIT scientists’ discovery yields a potent immune response, could be used to develop a potential tumor vaccine.
The researchers identified an atomic-level interaction that prevents peptide bonds from being broken down by water.
PhD student Oscar Molina seeks new ways to assemble proteins into targeted cancer therapies, while also encouraging his fellow first-generation graduate students.